TRAVERSA SERGIO
SEC CIK 1565832 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | CEO, Dir | 1.50M | $2.79M | $559.6K | 10 | 2022-06-30 | 2026-09-09 |
Most active insiders at RLMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shenouda Maged | CFO | $1.99M | — |
| 2 | TRAVERSA SERGIO | CEO, Dir | $1.54M | — |
| 3 | Ence Chuck | CAO, COO | $299.2K | — |
| 4 | Kelly Paul Edward | COO, Dir | $198.0K | — |
Transactions 10
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-11 07:30 | 2026-09-09+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $4.14 | +200.0K | 1.50M | +15% | +$828.0K |
| D | 2025-12-16 | 2025-12-15 | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $4.12 | +27.5K | 1.30M | +2% | +$113.3K |
| 2025-11-06 | 2025-11-05 | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $2.20 | +272.5K | 1.27M | +27% | +$599.5K | |
| M | 2025-08-28 | 2025-08-26+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $0.6696 | +266.0K | 944.0K | +39% | +$178.1K |
| M | 2025-05-20 | 2025-05-16+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $0.5007 | +350.0K | 556.3K | +170% | +$175.2K |
| M | 2024-09-11 | 2024-09-09+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $2.82 | +140.0K | 299.6K | +88% | +$395.1K |
| M | 2024-01-31 | 2024-01-29+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $3.87 | +100.0K | 244.0K | +69% | +$386.8K |
| 2022-12-12 | 2022-12-08 | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | P - Purchase | $2.10 | +55.2K | 144.0K | +62% | +$116.0K | |
| DM | 2022-07-05 | 2022-06-30+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | M - OptEx | $16.00 | +29.8K | 104.8K | +40% | +$476.3K |
| DM | 2022-07-05 | 2022-06-30+ | RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO, Dir | S - Sale+OE | $18.80 | -29.8K | 101.7K | -23% | -$559.6K |